Abstract C73: Anticancer effects of a novel phosphoinositol 3-kinase inhibitor in human hepatocellular carcinoma.
Ju‐Hee Lee(Dongguk University), Soon‐Sun Hong(Inha University), Ju-Hyeon Seo(Inha University), Hyun-Seung Lee(Korea Basic Science Institute), Guangyong Li(Ningxia Medical University), Kyung Hee Jung(Inha University), Sang‐Won Hong(Inha University), Sun‐Mi Yun(CHA University)
Cited by 0
Related Papers
Long-range interaction and correlation between <i>MYC</i> enhancer and oncogenic long noncoding RNA <i>CARLo-5</i>
|Proceedings of the National Academy of Sciences|2014|186
Mechanisms of Resistance to Histone Deacetylase Inhibitors
|Advances in cancer research|2012|101
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
|Biochemical and Biophysical Research Communications|2008|100
Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells
|Molecular Cancer Therapeutics|2006|100